drugset

drugset / Trial / NCT02097537

Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma

NCT02097537 ↗

Phase 3 Completed 10 enrolled Santen Pharmaceutical Co., Ltd.

NaSingle-groupOpen-labelPrevention

Summary

The Purpose of this study is to evaluate the safety and efficacy of SK-1211 inhalation challenge in children with bronchial asthma.

Timeline

Start: 2014-02
Primary completion: 2014-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Methacholine	Diagnostic / imaging agent	—	—

Indications